PT KALBE FARMA TBK. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,405 IDR | -1.75% |
|
+0.36% | -12.73% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
ETFs positioned on PT Kalbe Farma Tbk.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.30% | 9 M€ | -3.31% | - | |
| 1.91% | 93 M€ | +0.81% | ||
| 1.89% | 2 M€ | -14.14% | ||
| 1.54% | 15 M€ | +11.24% | ||
| 0.57% | 18 M€ | +3.66% | ||
| 0.17% | 11 M€ | +1.79% | ||
| 0.04% | 441 M€ | +4.60% | - | |
| 0.04% | 2,808 M€ | +5.90% | - | |
| 0.04% | 149 M€ | +2.17% | - | |
| 0.03% | 117 M€ | +1.11% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.01% | 7 M€ | +1.95% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 108 M€ | +2.03% | - | |
| 0.00% | 17 M€ | +1.44% | - | |
| 0.00% | 52 M€ | -0.60% | - | |
| 0.00% | 8 M€ | -0.60% | - |
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,405
IDR
Average target price
1,773
IDR
Spread / Average Target
+26.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.73% | 4.01B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- KLBF Stock
- Funds and ETFs PT Kalbe Farma Tbk.
